Related Experiment Video
Updated: Jan 22, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Nanotargeted agents: an emerging therapeutic strategy for breast cancer
Manling Du1, Yong Ouyang2, Fansu Meng3
1College of Pharmacy, Jinan University, Guangzhou 510632, PR China.
Abstract:
Breast cancer is the most common female cancer worldwide and represents 12% of all cancer cases. Improvements in survival rates are largely attributed to improved screening and diagnosis. Conventional chemotherapy remains an important treatment option but it is beset with poor cell selectivity, serious side effects and resistance. Nanoparticle drug delivery systems bring promising opportunities to breast cancer treatment. They may improve chemotherapy by targeting drugs to tumors, generating high drug concentrations at tumors providing slow release of the drug, increased drug stability and concomitant reductions in side effects. The nanotechnology-based drug delivery approaches and the current research and application status of nano-targeted agents for breast cancer are discussed in this review to provide a basis for further study on targeted drug delivery systems.
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Therapeutic Index
Subviral Agents
Applications of GIS: Disaster Management and Emergency Response
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

